DR. H. MOLZAHN, Intensieve Geneeskunde financials
A multi-period view of the public annual-account figures reported for DR. H. MOLZAHN, Intensieve Geneeskunde, with comparable measures and links to available source documents.
Company overviewRegistry number
0652611941
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 28, 2026
Financial evidence
Latest movements for DR. H. MOLZAHN, Intensieve Geneeskunde
2025 versus 2024
- Operating line
- €141,587
- EBITDA
- €141,187
- Total assets
- €600,439
- Equity
- €551,162
-5.9%
-6.2%
+0.6%
+7.2%
EBITDA margin +99.7% · Equity ratio +91.8%
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.